(Q39107261)

9 September 2017

Clinical course of multiple sclerosis: A nationwide cohort study (English)

1 reference

9 September 2017

0 references

Ali Manouchehrinia

1

1 reference

PubMed ID

27956559

9 September 2017

Omid Beiki

series ordinal

2

1 reference

PubMed ID

27956559

9 September 2017

Jan Hillert

series ordinal

3

1 reference

9 September 2017

12 December 2016

1 reference

Multiple Sclerosis Journal

9 September 2017

1 reference

9 September 2017

1352458516681197

1 reference

The clinical course of multiple sclerosis

9 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

New perspectives in the natural history of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

High nationwide prevalence of multiple sclerosis in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

High nationwide incidence of multiple sclerosis in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

The Swedish MS registry – clinical support tool and scientific resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

From the Gothenburg cohort to the Swedish multiple sclerosis registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Disability progression in multiple sclerosis is slower than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Age at disability milestones in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Evidence for a two-stage disability progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Natural history of multiple sclerosis in a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Disability profile of MS did not change over 10 years in a population-based prevalence cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

The natural history of secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516681197

21 January 2018

Identifiers

DOI

10.1177/1352458516681197

1 reference

9 September 2017

1 reference

PubMed ID

27956559